Copyright
©The Author(s) 2017.
World J Stem Cells. Apr 26, 2017; 9(4): 68-76
Published online Apr 26, 2017. doi: 10.4252/wjsc.v9.i4.68
Published online Apr 26, 2017. doi: 10.4252/wjsc.v9.i4.68
Study name | Clinical trials (gov ID) | Principal investigator | No. of included patients |
BOOST[10,18,19] | NCT00264316 | Stefan Janssens | Treated (n = 30) |
Control (n = 30) | |||
REPAIR-AMI[17,20,21] | NCT00279175 | Andreas Zeiher | Treated (n = 101) |
Control (n = 103) | |||
ASTAMI[23] | NCT00199823 | Ketil Lunde | Treated (n = 50) |
Control (n = 50) | |||
BALANCE[22] | - | Bodo-Eckehard Strauer | Treated (n = 62) |
Control (n = 62) | |||
SWISS-AMI[24] | NCT00355186 | Roberto Corti | Treated (n = 133) |
Control (n = 67) | |||
TIME[25] | NCT00684021 | Robert Simari | Treated (n = 79) |
Control (n = 41) | |||
Late TIME[26] | NCT00684060 | Robert Simari | Treated (n = 57) |
Control (n = 29) |
- Citation: Micheu MM, Dorobantu M. Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction. World J Stem Cells 2017; 9(4): 68-76
- URL: https://www.wjgnet.com/1948-0210/full/v9/i4/68.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v9.i4.68